{"id":"W2802172791","doi":"10.1200/jco.2017.77.2293","title":"Patient-Reported Symptoms and Impact of Treatment With Osimertinib Versus Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The AURA3 Trial","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"AstraZeneca","keywords":"Medicine; Lung cancer; Quality of life (healthcare); Internal medicine; Odds ratio; Hazard ratio; Cancer; Clinical trial; Performance status; Confidence interval; Chemotherapy; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003820286,0.0001347617,0.0009150266,0.00006974386,0.00003461828,0.000004574878,0.0000535362,0.0001302828,0.00007611978],"category_scores_gemma":[0.0001540808,0.00006114637,0.0002509691,0.0001379836,0.0002082101,0.0000527844,0.00001020839,0.0002163469,4.687321e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005320974,"about_ca_system_score_gemma":0.003334991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004063715,"about_ca_topic_score_gemma":0.0002561741,"domain_scores_codex":[0.9981481,0.0001140433,0.00127423,0.0001472817,0.0001491331,0.0001671695],"domain_scores_gemma":[0.9970727,0.0007654733,0.001543753,0.0001629793,0.0002881421,0.0001669538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3218827,0.003198833,0.2982274,0.00001282313,0.003181031,0.000129734,0.00163341,0.00006401155,0.0002862329,0.000002286595,0.0002418902,0.3711396],"study_design_scores_gemma":[0.4284899,0.2948983,0.2677865,0.0001660519,0.002381813,0.00007531689,0.0003421533,0.0002956813,0.0004603342,0.00001069447,0.004990033,0.000103267],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955652,0.0006382439,0.0000134493,0.001263839,0.0006843437,0.0007679833,0.00000420891,0.00000320341,0.001059506],"genre_scores_gemma":[0.9974751,0.001151276,0.0005363199,0.0002302957,0.0004718379,0.00002777787,0.000001679431,0.00001363288,0.00009206794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3710363,"threshold_uncertainty_score":0.5916131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05406334905879762,"score_gpt":0.4881889375538155,"score_spread":0.4341255884950179,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}